![Rodney Ho](https://depts.washington.edu/tlcart/wp-content/uploads/HO-2011-847x1024-847x1024-edit.jpg)
Dr. Rodney Ho is the TLC-ART principal investigator and program director, professor and presidential entrepreneurial fellow of the University of Washington. Read more.
![Dr. Bender Ignacio](https://depts.washington.edu/tlcart/wp-content/uploads/HutchOfficeShot_2023.png)
Dr. Rachel Bender Ignacio is the Clinical Lead for the TLC-ART Program and the Director of UW Positive Research. Read more.
Dr. Matthew Hartman is the Project Administrator for TLC-ART. He joined the lab in July of 2019 after finishing a postdoc in Political Science at the University of Notre Dame. Read More
![chris-jonsson](https://depts.washington.edu/tlcart/wp-content/uploads/chris-jonsson_resized-2-e1469214614806-edit.jpg)
Chris Jonsson, HeMBA is the Program Operations Manager for both the UW TLC-ART and UW ACTU programs. Read
![Zachary Stephen](https://depts.washington.edu/tlcart/wp-content/uploads/Zach-Stephen.jpg)
Dr. Zachary Stephen joined Dr. Ho’s lab as a Research Scientist in June 2021. He received his PhD from UW in 2016 and carried out his postdoctoral research in the Dept. of Materials Science and Engineering. Read More.
![](https://depts.washington.edu/tlcart/wp-content/uploads/IMG_6974-e1680864014384-696x1024.jpg)
Dr. Simone Perazzolo is a Sr Research Associate Scientist for physiologically-based mathematical/computational modeling (e.g. PBPK). He’s currently developing the PK understanding of drug-combo nanoparticles for long-acting therapies to be used in the treatment of HIV, HBV, cancer, and SARS-CoV2. Read More.
Dr. Masakatsu Eguchi received his PhD degree in Organic Chemistry from Brigham Young Univ. in 1990. He joined the lab as a research scientist in 2021. Dr. Eguchi has been actively involved in drug discovery efforts for 27 years, resulting in the development of 2 new investigational drugs. Read More.
Dr. Qingxin Mu joined Dr. Ho’s lab as a Research Scientist in June, 2017. He received his PhD degree in Shandong University in China, 2010. His current work focuses on formulation, characterization and evaluation of long-acting lipid-based drug combination nanoparticles for anticancer and anti-HIV drug delivery. Read More.
![Ken Garbutt](https://depts.washington.edu/tlcart/wp-content/uploads/Ken-Garbutt-233x300.jpg)
Ken Garbutt, MS has an MS in Molecular Biology from Wayne State Univ. He has worked in industry developing industrial enzymes, and has contributed to cullin-ring ubiquitin ligase research at UW. Ken joined the lab as a Research Scientist in March of 2022 and is on the formulation team. Read More.
![Jason Lo](https://depts.washington.edu/tlcart/wp-content/uploads/Jason-Lo-300x200.jpg)
Jason Lo, MS graduated from the Univ. of Michigan with a BS and an MS in Biomedical Engineering, then interned at Boehringer Ingelheim, Eli Lilly and Genentech. His role with TLC-ART is primarily focused on formulation development but also on analysis and characterization for the 301 Project. Read More.
Rachele Delle Fratte, MS is a Research Scientist II in Dr. Ho’s lab. She joined the team in November 2022, following the completion of her master’s degree in London, UK. She previously worked as a critical care nurse in the Medical ICU at Johns Hopkins Hospital in Baltimore, MD. Read More.
![Xiaolin (Alin)](https://depts.washington.edu/tlcart/wp-content/uploads/Xiaolin-Xu-profile-photo-3-244x300.jpg)